Research Analysts’ Updated EPS Estimates for March 19th (ABEO, ACRS, ALL, AT, ATYM, BGSI, BTSG, CAPD, CIFR, CKN)

Research Analysts’ updated eps estimates for Thursday, March 19th:

Abeona Therapeutics (NASDAQ:ABEO) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $20.00 target price on the stock.

Aclaris Therapeutics (NASDAQ:ACRS) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $16.00 target price on the stock.

Atlantic Lithium (LON:ALL) had its speculative buy rating reiterated by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a GBX 37 price target on the stock.

Ashtead Technology (LON:AT) had its buy rating reiterated by analysts at Stifel Nicolaus. The firm currently has a GBX 600 price target on the stock.

Atalaya Mining (LON:ATYM) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. The firm currently has a GBX 1,090 target price on the stock.

Boyd Group Services (NYSE:BGSI) had its overweight rating reissued by analysts at Stephens. Stephens currently has a $200.00 price target on the stock.

BrightSpring Health Services (NASDAQ:BTSG) had its buy rating reissued by analysts at BTIG Research. They currently have a $55.00 price target on the stock.

Capital (LON:CAPD) had its buy rating reissued by analysts at Stifel Nicolaus. The firm currently has a GBX 200 target price on the stock.

Cipher Mining (NASDAQ:CIFR) had its buy rating reiterated by analysts at Rosenblatt Securities. The firm currently has a $24.00 target price on the stock.

Clarkson (LON:CKN) had its hold rating reaffirmed by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a GBX 4,400 price target on the stock.

CSX (NASDAQ:CSX) was downgraded by analysts at Evercore Inc from an outperform rating to an in-line rating. The firm currently has $41.00 price target on the stock.

Darden Restaurants (NYSE:DRI) had its equal weight rating reaffirmed by analysts at Stephens. The firm currently has a $205.00 target price on the stock.

Energean (LON:ENOG) had its buy rating reissued by analysts at Stifel Nicolaus. Stifel Nicolaus currently has a GBX 1,100 target price on the stock.

4D Molecular Therapeutics (NASDAQ:FDMT) had its buy rating reiterated by analysts at Chardan Capital. Chardan Capital currently has a $26.00 price target on the stock.

Freshworks (NASDAQ:FRSH) was downgraded by analysts at Oppenheimer Holdings, Inc. from an outperform rating to a market perform rating.

GE HealthCare Technologies (NASDAQ:GEHC) had its buy rating reissued by analysts at BTIG Research. BTIG Research currently has a $91.00 price target on the stock.

Grafton Group (LON:GFTU) had its buy rating reaffirmed by analysts at Stifel Nicolaus. They currently have a GBX 1,175 target price on the stock.

Globant (NYSE:GLOB) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $60.00 target price on the stock.

The Gym Group (LON:GYM) had its buy rating reiterated by analysts at Shore Capital Group Ltd.

Harrow (NASDAQ:HROW) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $70.00 price target on the stock.

Jadestone Energy (LON:JSE) had its buy rating reaffirmed by analysts at Stifel Nicolaus. The firm currently has a GBX 70 price target on the stock.

Kinsale Capital Group (NYSE:KNSL) was downgraded by analysts at Jefferies Financial Group Inc. from a hold rating to an underperform rating. Jefferies Financial Group Inc. currently has $312.00 price target on the stock.

Life360 (NASDAQ:LIF) was downgraded by analysts at DA Davidson from a buy rating to a neutral rating. They currently have $40.00 price target on the stock, down from their previous price target of $70.00.

Micron Technology (NASDAQ:MU) was downgraded by analysts at Summit Insights from a buy rating to a hold rating.

N-able (NYSE:NABL) had its buy rating reiterated by analysts at Needham & Company LLC. Needham & Company LLC currently has a $8.00 target price on the stock.

PCI-PAL (LON:PCIP) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. The firm currently has a GBX 115 target price on the stock.

Protalix BioTherapeutics (NYSE:PLX) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $12.00 price target on the stock.

Pelthos Therapeutics (NYSEAMERICAN:PTHS) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $60.00 target price on the stock.

Rockhopper Exploration (LON:RKH) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. The firm currently has a GBX 113 price target on the stock.

Softcat (LON:SCT) had its buy rating reiterated by analysts at Shore Capital Group Ltd.

Sarepta Therapeutics (NASDAQ:SRPT) had its outperform rating reaffirmed by analysts at Oppenheimer Holdings, Inc.. Oppenheimer Holdings, Inc. currently has a $37.00 target price on the stock.

Stoke Therapeutics (NASDAQ:STOK) had its buy rating reiterated by analysts at BTIG Research. The firm currently has a $39.00 price target on the stock.

tinyBuild (LON:TBLD) had its hold rating reissued by analysts at Shore Capital Group Ltd.

Trainline (LON:TRN) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a GBX 330 price target on the stock.

TeraWulf (NASDAQ:WULF) had its buy rating reaffirmed by analysts at Rosenblatt Securities. They currently have a $23.00 target price on the stock.

Xponential Fitness (NYSE:XPOF) had its market perform rating reaffirmed by analysts at Raymond James Financial, Inc..